Revenio Group
25 EUR -1.42%Revenio is a medical technology company. Within the Group, there is research and development of pressure measurement technology that is used in the treatment of a number of diseases such as glaucoma, osteoporosis, skin cancer, and asthma. Operations are held worldwide and are run via most subsidiaries, each with a business focus. The company's head office is located in Vantaa.
Log in to see the recommendation and risk by Inderes
Latest research
Extensive report
Analyst
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
William Demant Invest A/S | 18.0 % | 18.0 % |
SEB Funds | 4.0 % | 4.0 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
John Floyd | 20.02.2024 | 22,128EUR |
Kate Taylor | 16.02.2024 | 13,820EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 61.1 | 78.8 | 97.0 | 96.6 | 104.6 | 120.1 | 140.1 | 159.8 |
growth-% | 23.4 % | 29.1 % | 23.1 % | -0.5 % | 8.3 % | 14.8 % | 16.7 % | 14.0 % |
EBITDA | 21.7 | 25.7 | 33.1 | 30.3 | 33.4 | 41.2 | 48.5 | 56.2 |
EBIT (adj.) | 19.2 | 24.5 | 30.9 | 28.5 | 30.4 | 37.9 | 45.0 | 52.3 |
EBIT | 17.1 | 22.1 | 29.7 | 26.3 | 29.4 | 36.9 | 44.1 | 51.4 |
Profit before taxes | 16.7 | 22.1 | 29.1 | 25.4 | 29.0 | 37.3 | 45.0 | 53.0 |
Net income | 13.3 | 17.3 | 21.8 | 19.1 | 22.3 | 28.7 | 34.6 | 40.8 |
EPS (adj.) | 0.58 | 0.74 | 0.86 | 0.80 | 0.88 | 1.12 | 1.34 | 1.57 |
growth-% | 22.5 % | 27.2 % | 16.9 % | -7.5 % | 9.8 % | 27.0 % | 20.0 % | 17.0 % |
Dividend | 0.32 | 0.34 | 0.36 | 0.38 | 0.42 | 0.58 | 0.73 | 0.92 |
Dividend ratio | 63.7 % | 52.4 % | 43.9 % | 52.9 % | 50.0 % | 54.0 % | 56.0 % | 60.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 35.5 % | 32.6 % | 34.1 % | 31.4 % | 32.0 % | 34.3 % | 34.6 % | 35.2 % |
EBIT-% (adj.) | 31.4 % | 31.1 % | 31.8 % | 29.5 % | 29.1 % | 31.5 % | 32.1 % | 32.7 % |
EBIT-% | 28.0 % | 28.0 % | 30.6 % | 27.3 % | 28.1 % | 30.7 % | 31.5 % | 32.2 % |
ROE | 19.9 % | 23.4 % | 25.7 % | 20.0 % | 21.1 % | 23.7 % | 24.9 % | 25.6 % |
ROI | 17.9 % | 22.1 % | 27.6 % | 23.3 % | 24.3 % | 27.4 % | 29.1 % | 30.2 % |
Login required
This content is only available for logged in users
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 50.30 | 55.55 | 38.60 | 27.16 | 25.00 | 25.00 | 25.00 | 25.00 |
Shares | 26.6 | 26.7 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
Market cap | 1,336.9 | 1,482.1 | 1,026.0 | 721.9 | 664.5 | 664.5 | 664.5 | 664.5 |
Enterprise value | 1,334.9 | 1,482.0 | 1,014.6 | 718.9 | 645.5 | 625.1 | 602.9 | 577.9 |
EV/S | 21.9 | 18.8 | 10.5 | 7.4 | 6.2 | 5.2 | 4.3 | 3.6 |
EV/EBITDA | 61.5 | 57.7 | 30.6 | 23.7 | 19.3 | 15.2 | 12.4 | 10.3 |
EV/EBIT (adj.) | 69.5 | 60.4 | 32.9 | 25.2 | 21.2 | 16.5 | 13.4 | 11.1 |
EV/EBIT | 78.1 | 67.1 | 34.2 | 27.3 | 21.9 | 16.9 | 13.7 | 11.2 |
P/E (adj.) | 86.6 | 75.1 | 44.6 | 34.0 | 28.5 | 22.4 | 18.7 | 16.0 |
P/E | 100.2 | 85.7 | 47.1 | 37.8 | 29.7 | 23.1 | 19.2 | 16.3 |
P/B | 19.2 | 18.9 | 11.3 | 7.2 | 5.9 | 5.1 | 4.5 | 3.9 |
P/S | 21.9 | 18.8 | 10.6 | 7.5 | 6.4 | 5.5 | 4.7 | 4.2 |
Dividend yield | 0.6 % | 0.6 % | 0.9 % | 1.4 % | 1.7 % | 2.3 % | 2.9 % | 3.7 % |
Equity ratio | 60.9 % | 63.0 % | 66.8 % | 72.7 % | 74.4 % | 75.4 % | 75.9 % | 76.0 % |
Gearing ratio | -2.7 % | -12.5 % | -2.9 % | -16.8 % | -30.3 % | -41.3 % | -50.8 % |
Login required
This content is only available for logged in users
Quarter data
Q1/23 | Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24e | Q2/24e | Q3/24e | Q4/24e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 23.2 | 22.3 | 22.0 | 29.1 | 96.6 | 22.9 | 24.0 | 25.3 | 32.5 |
EBITDA | 7.1 | 5.6 | 7.1 | 10.5 | 30.3 | 6.5 | 6.8 | 8.3 | 11.8 |
EBIT | 6.2 | 4.7 | 6.0 | 9.5 | 26.3 | 5.5 | 5.8 | 7.3 | 10.8 |
Profit before taxes | 5.8 | 4.5 | 5.9 | 9.2 | 25.4 | 5.4 | 5.7 | 7.2 | 10.7 |
Net income | 4.2 | 3.3 | 4.4 | 7.1 | 19.1 | 4.1 | 4.4 | 5.6 | 8.2 |
Login required
This content is only available for logged in users
Invitation to Revenio Group Corporation’s audiocast and teleconference call
Decisions of Revenio Group Corporation's Annual General Meeting and the organizing meeting of the Board of Directors
Join Inderes community
Don't miss out - create an account and get all the possible benefits